Author/Creator: Halmos, B - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Halmos, B

1. 1396PEfficacy and safety of crizotinib in previously treated patients (Pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y). (23rd October 2018)

Authors:: Moro-Sibilot, D; Ahn, M-J; Halmos, B; Kim, D-W; Riely, G J; Shaw, A T; Yang, P-C; Lanzalone, S; Polli, A; Wilner, K D; De Castro Carpeño, J
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1456PPhase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results. (23rd October 2018)

Authors:: Reckamp, K L; Gilman, P; Halmos, B; Jahanzeb, M; McCann, J; Paripati, H; Seneviratne, L C; Wallace, J A; Rueter, B; Esler, A; Dowling, E; Koczywas, M
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 1897PDDifferential expression of immune checkpoints (PD-L1, HHLA2, B7x and B7H3) and their association with driver mutations in pulmonary sarcomatoid carcinoma (PSC). (23rd October 2018)

Authors:: Cheng, H; Sharma, J; Su, C; Li, S; Zang, X; Perez-Soler, R; Halmos, B; Borczuk, A
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 489POverall survival in patients with EGFRm+ NSCLC receiving sequential afatinib and osimertinib: Updated analysis of the GioTag study. (24th November 2019)

Authors:: Hochmair, M J; Morabito, A; Hao, D; Yang, C-T; Soo, R A; Yang, J C-H; Gucalp, R; Halmos, B; Wang, L; Märten, A; Cufer, T
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 9
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. LBA7Afatinib followed by osimertinib in patients with EGFR mutation-positive advanced NSCLC: A real-world study (GioTag). (25th November 2018)

Authors:: Hochmair, M J; Morabito, A; Hao, D; Yang, C-T; Soo, R A; Yang, J C-H; Gucalp, R; Halmos, B; Wang, L; Golembesky, A; Märten, A; Cufer, T
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 9
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Simpson's paradox – aggregating and partitioning populations in health disparities of lung cancer patients. (December 2015)

Authors:: Fu, P; Panneerselvam, A; Clifford, B; Dowlati, A; Ma, PC; Zeng, G; Halmos, B; Leidner, RS
Journal:: Statistical methods in medical research
Issue:: Volume 24:Number 6(2015:Dec.)
Page Start:: 937
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗